Anti-HGFR/c-Met Antibody (Telisotuzumab)
Catalog No.
F1522
Anti-HGFR/c-Met Antibody (Telisotuzumab)
Featured Products
Telisotuzumab (ABT-700) is a humanized recombinant bivalent antibody, a therapeutic antibody targeting hepatocyte growth factor receptor (MET), which can bind to c-Met with high affinity and inhibit c-Met signaling. Telisotuzumab has anti-tumor activity.
Quality Control & DataSheet
- View current batch:
146.1 kDa
Dry ice
1781223-80-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
h224G11, ABT-700
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P08581
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The purity of Anti-HGFR/c-Met Antibody (Telisotuzumab) is 99.49%, determined by SEC-HPLC.
HGFR / c-Met
Please avoid freeze-thaw cycles.